689 results on '"Meyer, Claus"'
Search Results
2. Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
3. Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study
4. The recombinome of IKZF1 deletions in B-cell precursor ALL
5. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study
6. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
7. Prenatal origin of NUTM1 gene rearrangement in infant B‐cell precursor acute lymphoblastic leukaemia.
8. KMT2A-ARHGEF12, a therapy related fusion with poor prognosis
9. IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia
10. Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study
11. Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions
12. Diagnostic Tool for the Identification of MLL Rearrangements Including Unknown Partner Genes
13. A human genome editing-based MLL::AF4 B-cell ALL model recapitulates key cellular and molecular leukemogenic features
14. P315: TP53 ALTERATIONS AND MRD REFINE PROGNOSIS OF ADULT KMT2A-REARRANGED B-ALL
15. The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome
16. Table S1 from Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia
17. Data from Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia
18. Figure S1 from Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia
19. A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
20. Supplementary Methods, Figures S1-S8, Tables S1-S7 from Effective Targeting of the P53–MDM2 Axis in Preclinical Models of Infant MLL-Rearranged Acute Lymphoblastic Leukemia
21. The recombinome of IKZF1 deletions in B-ALL
22. 3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA
23. Molecular Characterization of 34 Children with Acute Leukemia and MLL gene Rearrangements in Argentina
24. Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias
25. MLL partner genes in secondary acute lymphoblastic leukemia: Report of a new partner PRRC1 and review of the literature
26. The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
27. Analyzing acute leukemia patients with complex MLL rearrangements by a sequential LDI-PCR approach
28. Functional analysis of the two reciprocal fusion genes MLL-NEBL and NEBL-MLL reveal their oncogenic potential
29. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
30. Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution
31. Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias
32. Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report
33. The recombinome of IKZF1deletions in B-cell precursor ALL
34. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling
35. High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)
36. Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory
37. KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints
38. Complex and cryptic chromosomal rearrangements involving the MLL gene in acute leukemia: A study of 7 patients and review of the literature
39. FISH-negative cryptic PML–RARA rearrangement detected by long-distance polymerase chain reaction and sequencing analyses: a case study and review of the literature
40. Three-way translocation involving MLL, MLLT1, and a novel third partner, NRXN1, in a patient with acute lymphoblastic leukemia and t(2;19;11) (p12;p13.3;q23)
41. Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after hemophagocytic lymphohistiocytosis
42. KMT2A-MLLT1 and the Novel SEC16A-KMT2A in a Cryptic 3-Way Translocation t(9;11;19) Present in an Infant With Acute Lymphoblastic Leukemia
43. KMT2A-CBLrearrangements in acute leukemias: clinical characteristics and genetic breakpoints
44. Targeted Next Generation Sequencing Reveals a Third Breakpoint Cluster Region and New Partner Genes in the KMT2A Recombinome
45. Implication of ICOSLG on Relapse in Infant T(4;11) Acute Lymphoblastic Leukemia
46. Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia
47. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group
48. Epigenetic regulator genes direct lineage switching in MLL-AF4 leukaemia
49. Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
50. Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.